While non-canonical NF-κB RELB signaling is described to be mostly present in hematological cancers, solid cancers reveal constitutive canonical NF-κB RELA or c-REL activity. The gene discussed is NFKB1; the disease is hematopoietic and lymphoid cell neoplasm.